Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 25 June 2007. doi:10.1136/hrt.2006.110023
Heart 2008;94:305-310
Copyright © 2008 BMJ Publishing Group Ltd & British Cardiovascular Society

ACUTE CORONARY SYNDROMES

Increased granzyme B production from peripheral blood mononuclear cells in patients with acute coronary syndrome

R Tsuru1, H Kondo1, Y Hojo1, M Gama1, O Mizuno1, T Katsuki1, K Shimada1, M Kikuchi2, T Yashiro2

1 Department of Cardiology, Jichi Medical University, Tochigi, Japan
2 Department of Anatomy, Jichi Medical University, Tochigi, Japan

Yukihiro Hojo M.D., Department of Cardiology, Jichi Medical University, 3311 Yakushiji, Shimotsuke-city, Tochigi, 329-0498, Japan; yhojo{at}jichi.ac.jp

ABSTRACT

Objectives: To clarify the role of granzyme B in acute coronary syndrome.

Design and Setting: Granzyme B is a member of the serine esterase family released from cytotoxic lymphocytes and plays an important role in cellular apoptosis by activating intracellular caspases. Granzyme B expression was compared between patients with stable and unstable angina pectoris (UAP).

Patients: 173 patients with coronary artery disease (CAD) were enrolled. 84 patients were found to have stable angina pectoris (SAP) and 89 patients to have UAP.

Methods: Peripheral blood was drawn from the patients. Peripheral blood mononuclear cells (PBMCs) isolated by gradient centrifugation were cultured at a density of 2x106 cells/ml for 24 hours. The supernatants were collected 24 hours after incubation and the granzyme B level was measured by enzyme-linked immunosorbent assay. Polychromic flow cytometric analysis was performed to evaluate the expression of granzyme B in the cells.

Results: Granzyme B production from PBMCs of UAP patients was significantly higher than from those of patients with SAP (39.1 (SEM 6.6) versus 17.0 (SEM 1.8) pg/ml, p<0.05). Granzyme B production from PBMCs increased with the increasing TIMI risk score in UAP patients. The percentage of granzyme B-positive lymphocytes to CD3-positive lymphocytes in UAP patients was significantly higher than in SAP (32.1% (SEM 1.6%) versus 18.4% (SEM 0.9%), p<0.01).

Conclusions: These results suggest that granzyme B might play an important role in triggering acute coronary events by inducing apoptosis and the degradation of atherosclerotic coronary plaques.

Keywords: atherosclerosis; apoptosis; plaque rupture; inflammation; cytokine


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Iijima, R, Byrne, R A, Ndrepepa, G, Braun, S, Mehilli, J, Berger, P B, Schomig, A, Kastrati, A (2009). Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials. Heart 95: 107-112 [Abstract] [Full Text]  
  • Buzza, M. S., Dyson, J. M., Choi, H., Gardiner, E. E., Andrews, R. K., Kaiserman, D., Mitchell, C. A., Berndt, M. C., Dong, J.-F., Bird, P. I. (2008). Antihemostatic Activity of Human Granzyme B Mediated by Cleavage of von Willebrand Factor. J. Biol. Chem. 283: 22498-22504 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.